Technical Guide

Pharmaceutical Pellets: Formulation Guide

A guide to pharmaceutical pellets for formulators. Learn about pelletisation, release designations and what to confirm when evaluating a pellet specification.

Updated

White pharmaceutical pellets in a stainless steel sampling dish beside a sampling scoop

Pharmaceutical pellets, also called pharma pellets, are discrete solid units that can be filled into capsules or incorporated into other dosage forms. This guide explains how pelletisation, coating and downstream processing influence what a formulator asks for in a material specification.

Formulators can use pellets to design multiparticulate dosage forms. The choice of pellet, coating and downstream process depends on the target release profile, handling requirements and compatibility with the finished formulation.

For product-specific evaluation, explore pharmaceutical pellet formulations and confirm your requirements with the team.

What Exactly Are Pharmaceutical Pellets?

Pellets are typically rounded. They can carry an active ingredient in a core or layer, and a coating can be part of the release design. The size distribution and handling characteristics should be chosen for the filling, blending or tableting process and verified for the intended material.

The Pelletization Process

Pelletisation can involve shaping a wet mass or layering material onto starter cores. The process and coating are selected for the formulation and its handling and release requirements. Verify the proposed process with the supplier for the specific material under review.

Types of Pharmaceutical Pellets

Common pellet designations describe different release objectives.

Immediate Release (IR) Pellets

Immediate-release pellets are designed to release the active ingredient without an intentional delay or extension. Review the applicable dissolution method and criteria for the proposed material.

Sustained Release (SR) Pellets

Sustained-release pellets use a formulation or coating intended to extend release over time. Compare the exact designation, test time points and acceptance criteria in the specification.

Enteric Coated Pellets

Enteric-coated pellets are designed to resist release under acidic test conditions and release under specified later conditions. Review the media, timing, acid-resistance criteria and subsequent release criteria for the particular product.

For an example of how to scope the enquiry, see the Esomeprazole EC Pellets reference. For regulatory background on finished oral dosage forms, see the EMA guideline on oral modified-release product quality.

Why Partner with Rraynex for Pellet Manufacturing?

Rraynex specialises in pharmaceutical pellets and granules. When evaluating a pellet, share the intended dosage form, release requirements and quantity. Ask which specifications and test documents apply to the proposed material.

Understanding Release Mechanisms

Ask the supplier to explain the role of the coating or matrix and how downstream handling may affect it. For a multi-unit pellet system, confirm the intended dosage form and assess release after downstream processing as part of formulation development.

For a MUPS tablet project, assess whether blending and compression affect pellet integrity and compare the release of the proposed material under relevant test conditions. The Omeprazole MUPS reference lists the questions to include when requesting the specification.

For a test-by-test comparison and a MUPS trial checklist, see enteric-coated vs. sustained-release pellets.

Ready to Optimize Your Formulation?

Use the catalogue and enquiry form to discuss the pellet specifications required for your project.

Contact Our Team Today to request a sample or discuss your project requirements.

Frequently Asked Questions

Are all pharmaceutical pellets interchangeable?

No. Drug loading, particle size, coating, release behaviour and intended processing can differ. Suitability requires a product-specific technical assessment.

Which documents should a procurement enquiry request?

Ask which specifications, batch Certificates of Analysis, stability information and relevant quality documents are available for the specific product and manufacturing site. Availability should be confirmed directly.

Put insight into practice

Let’s discuss your
next formulation project.

Share your product, strength, release requirements, expected quantity and destination market with our team.

Discuss your product requirements

Share this article

LinkedInXWhatsApp

Back to all insights
View all insights